Structure (Oxaliplatin 01)
Chemical structure of oxaliplatin showing a platinum center coordinated to a cyclohexane diamine ligand and two oxalate groups.*
Oxaliplatin Injection, Solution
Product Images NDC 60505-6132
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Oxaliplatin (NDC 60505-6132). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Oxaliplatin 02)
A Kaplan-Meier survival curve chart depicting disease-free survival (DFS) probability over time in months for two treatment arms: FOLFOX4 and LV5FU2. The chart includes a legend with number of events and percentages for each arm, hazard ratio with 95% confidence interval, and p-value from stratified logrank test. Patient numbers at risk are shown at multiple time points up to 72 months.*
Figure 2 (Oxaliplatin 03)
A survival curve chart showing Disease-Free Survival (DFS) probability over months (0 to 72) comparing two treatment arms: FOLFOX4 and LV5FU2, both combined with DUKES C stage. The chart includes a hazard ratio of 0.78 with a 95% confidence interval of 0.65 to 0.93 and a log-rank test p-value of 0.005.*
Figure 3 (Oxaliplatin 04)
A survival curve graph showing percentage of patients surviving over 24 months for three treatments: Oxaliplatin Injection USP plus 5-FU/LV, Oxaliplatin Injection USP plus irinotecan, and irinotecan plus 5-FU/LV. The graph includes median survival times and a statistical significance note (p < 0.0001).*
50 mg/10 mL Container (Oxaliplatin 05)
Oxaliplatin Injection, USP 50 mg/10 mL (5 mg/mL) vial label for intravenous use by Apotex Corp. The label includes dosage strength, administration instructions, and cautions including 'Contains Cytotoxic Agent.' Manufactured by Qilu Pharmaceutical (Hainan) Co., Ltd., China, and labeled for Apotex Corp. in Weston, Florida, USA.*
50 mg/10 mL Carton (Oxaliplatin 06)
Carton label for Oxaliplatin Injection, USP 50 mg/10 mL (5 mg/mL) intravenous solution by Apotex Corp. The label states it is for intravenous use only, sterile aqueous solution without preservatives, contains cytotoxic agent, and cautions against mixing with sodium chloride-containing solutions. Manufactured by Qilu Pharmaceutical (Hainan) Co., Ltd. in China for Apotex Corp., Weston, Florida. Storage instructions and other cautions are provided.*
100 mg/20 mL Container (Oxaliplatin 07)
Label for Oxaliplatin Injection, USP 100 mg/20 mL (5 mg/mL) intravenous solution by Apotex Corp. The label states it is a sterile aqueous solution in a 20 mL single-dose vial, preservative free, with instructions not to mix or add to sodium chloride-containing solutions. Manufactured by Qilu Pharmaceutical (Hainan) Co., Ltd. in China and labeled by Apotex Corp., Weston, Florida.*
100 mg/20 mL Container (Oxaliplatin 08)
Packaging label for Oxaliplatin Injection, USP, 100 mg/20 mL (5 mg/mL) intravenous solution by Apotex Corp. The label states the product is for intravenous use only, sterile, preservative-free, and contains a cytotoxic agent. The label includes storage instructions, manufacturing details by Qilu Pharmaceutical (Hainan) Co., Ltd., and warnings against mixing with sodium chloride or chloride-containing solutions.*
200 mg/40 mL Container (Oxaliplatin 09)
The label is for Oxaliplatin Injection, USP 200 mg/40 mL (5 mg/mL) solution for intravenous use. It is a sterile aqueous single-dose vial labeled with Apotex Corp. as the labeler and manufactured by Qilu Pharmaceutical in China. The label includes a barcode, lot number, expiration date (05/2022), and cautions about dilution and storage.*
200 mg/40 mL Carton (Oxaliplatin 10)
Oxaliplatin Injection, USP 200 mg/40 mL (5 mg/mL) in a single-dose vial labeled for intravenous use only. The label includes caution for cytotoxic agent handling, manufacturer information (Qilu Pharmaceutical, China), and distributor (Apotex Corp., USA). Storage instructions and warnings about preservative-free saline solutions are also present.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
